Dr. Christopher Sheppard, MD

NPI: 1306924964
Total Payments
$581,700
2024 Payments
$2,142
Companies
36
Transactions
1,580
Medicare Patients
709
Medicare Billing
$3.2M

Payment Breakdown by Category

Other$476,751 (82.0%)
Consulting$58,677 (10.1%)
Food & Beverage$26,393 (4.5%)
Travel$19,256 (3.3%)
Education$623.71 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $475,951 211 81.8%
Consulting Fee $58,677 20 10.1%
Food and Beverage $26,393 1,164 4.5%
Travel and Lodging $19,256 173 3.3%
Honoraria $800.00 1 0.1%
Education $623.71 11 0.1%

Top Paying Companies

Company Total Records Latest Year
GENZYME CORPORATION $351,199 432 $0 (2024)
Biogen, Inc. $53,725 293 $0 (2024)
Genentech USA, Inc. $46,835 158 $0 (2024)
Novartis Pharmaceuticals Corporation $29,016 135 $0 (2024)
EMD Serono, Inc. $22,676 127 $0 (2024)
Acorda Therapeutics, Inc $18,963 47 $0 (2024)
Mallinckrodt Enterprises LLC $17,480 59 $0 (2019)
Teva Pharmaceuticals USA, Inc. $15,139 63 $0 (2019)
Celgene Corporation $13,144 82 $0 (2024)
E.R. Squibb & Sons, L.L.C. $6,755 10 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,142 113 EMD Serono, Inc. ($345.11)
2023 $2,626 120 GENZYME CORPORATION ($481.15)
2022 $2,211 119 Alexion Pharmaceuticals, Inc. ($421.25)
2021 $28,194 144 GENZYME CORPORATION ($7,168)
2020 $27,825 93 Celgene Corporation ($7,816)
2019 $109,926 251 GENZYME CORPORATION ($58,996)
2018 $181,262 328 GENZYME CORPORATION ($130,725)
2017 $227,514 412 GENZYME CORPORATION ($151,322)

All Payment Transactions

1,580 individual payment records from CMS Open Payments — Page 1 of 64

Date Company Product Nature Form Amount Type
12/18/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $27.21 General
12/17/2024 Genentech USA, Inc. Ocrevus (Biological), Ocrevus Zunovo Food and Beverage In-kind items and services $23.39 General
Category: Immunology
12/16/2024 Biogen, Inc. TYSABRI (Biological), VUMERITY Food and Beverage In-kind items and services $13.02 General
Category: Neurology
12/11/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Food and Beverage In-kind items and services $19.81 General
Category: Immunology
12/04/2024 GENZYME CORPORATION Food and Beverage In-kind items and services $20.66 General
11/26/2024 Biogen, Inc. VUMERITY (Drug) Food and Beverage In-kind items and services $22.68 General
Category: Neurology
11/22/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $13.48 General
Category: Neuroscience
11/22/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $2.36 General
Category: Neuroscience
11/22/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $2.14 General
Category: Neuroscience
11/19/2024 Genentech USA, Inc. Ocrevus (Biological), Ocrevus Zunovo Food and Beverage In-kind items and services $22.16 General
Category: Immunology
11/18/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $13.35 General
Category: Neurology
11/15/2024 Biogen, Inc. VUMERITY (Drug) Food and Beverage In-kind items and services $18.57 General
Category: Neurology
11/14/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $20.58 General
11/08/2024 Genentech USA, Inc. Enspryng (Biological) Food and Beverage In-kind items and services $19.83 General
Category: Immunology
11/08/2024 Genentech USA, Inc. Enspryng (Biological) Food and Beverage In-kind items and services $0.87 General
Category: Immunology
11/06/2024 GENZYME CORPORATION Food and Beverage In-kind items and services $127.01 General
11/04/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $15.48 General
Category: Neuroscience
11/04/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $3.06 General
Category: Neuroscience
11/04/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $1.46 General
Category: Neuroscience
10/31/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $21.90 General
Category: Rare Disease
10/30/2024 Sandoz Inc. Food and Beverage In-kind items and services $16.03 General
10/29/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $21.48 General
10/28/2024 Cycle Pharmaceuticals Inc Tascenso ODT (Drug) Food and Beverage In-kind items and services $21.43 General
Category: NEUROLOGY
10/25/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $17.25 General
10/24/2024 Genentech USA, Inc. Ocrevus (Biological), Ocrevus Zunovo Food and Beverage In-kind items and services $23.39 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 132 14,051 $2.3M $615,740
2022 6 156 18,286 $3.0M $807,874
2021 6 202 26,241 $4.3M $1.1M
2020 7 219 15,707 $2.6M $674,257
Total Patients
709
Total Services
74,285
Medicare Billing
$3.2M
Procedure Codes
25

All Medicare Procedures & Services

25 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J2350 Injection, ocrelizumab, 1 mg Office 2023 14 13,800 $2.2M $605,082 27.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 53 72 $17,208 $5,922 34.4%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2023 17 31 $18,600 $2,595 13.9%
96415 Administration of chemotherapy into vein, each additional hour Office 2023 16 90 $11,700 $1,724 14.7%
96375 Injection of additional new drug or substance into vein Office 2023 16 29 $1,972 $303.14 15.4%
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg Office 2023 16 29 $580.00 $114.41 19.7%
J2350 Injection, ocrelizumab, 1 mg Office 2022 18 18,000 $2.9M $796,454 27.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 62 76 $18,164 $5,512 30.3%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2022 19 35 $21,000 $3,265 15.5%
96415 Administration of chemotherapy into vein, each additional hour Office 2022 19 105 $13,650 $2,110 15.5%
96375 Injection of additional new drug or substance into vein Office 2022 19 35 $2,380 $384.04 16.1%
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg Office 2022 19 35 $700.00 $147.53 21.1%
J2350 Injection, ocrelizumab, 1 mg Office 2021 28 25,800 $4.2M $1.1M 26.0%
96413 Infusion of chemotherapy into a vein up to 1 hour Office 2021 33 65 $39,000 $6,436 16.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 56 72 $17,208 $5,216 30.3%
96415 Infusion of chemotherapy into a vein Office 2021 28 168 $21,840 $3,625 16.6%
96375 Injection of different drug or substance into a vein for therapy, diagnosis, or prevention Office 2021 28 56 $3,808 $664.56 17.5%
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg Office 2021 29 80 $1,600 $233.49 14.6%
J2350 Injection, ocrelizumab, 1 mg Office 2020 23 15,300 $2.5M $656,633 26.4%
96413 Infusion of chemotherapy into a vein up to 1 hour Office 2020 36 99 $59,400 $9,778 16.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 62 80 $19,120 $4,390 23.0%
96415 Infusion of chemotherapy into a vein Office 2020 26 105 $13,650 $2,210 16.2%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 20 21 $3,423 $654.02 19.1%
96375 Injection of different drug or substance into a vein for therapy, diagnosis, or prevention Office 2020 26 35 $2,380 $407.77 17.1%
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg Office 2020 26 67 $1,340 $183.91 13.7%

About Dr. Christopher Sheppard, MD

Dr. Christopher Sheppard, MD is a Internal Medicine healthcare provider based in Uniontown, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306924964.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Sheppard, MD has received a total of $581,700 in payments from pharmaceutical and medical device companies, with $2,142 received in 2024. These payments were reported across 1,580 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($475,951).

As a Medicare-enrolled provider, Sheppard has provided services to 709 Medicare beneficiaries, totaling 74,285 services with total Medicare billing of $3.2M. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Neurology
  • Location Uniontown, OH
  • Active Since 11/01/2006
  • Last Updated 02/10/2015
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1306924964

Products in Payments

  • LEMTRADA (Drug) $217,339
  • AUBAGIO (Drug) $124,056
  • OCREVUS (Biological) $37,862
  • TECFIDERA (Drug) $31,263
  • ACTHAR (Biological) $19,923
  • ZEPOSIA (Drug) $18,987
  • AMPYRA (Drug) $18,963
  • Mavenclad (Biological) $16,787
  • COPAXONE (Drug) $14,787
  • TYSABRI (Biological) $14,627
  • GILENYA (Drug) $10,809
  • Non-Covered Product (Drug) $8,292
  • MAYZENT (Drug) $7,378
  • Mavenclad (Drug) $4,609
  • DISEASE STATE (Drug) $3,579
  • VUMERITY (Drug) $2,141
  • Bafiertam (Drug) $800.00
  • KESIMPTA (Drug) $749.97
  • Ocrevus (Biological) $551.26
  • SOLIRIS (Biological) $476.23

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Uniontown